Atara Biotherapeutics, Inc. (ATRA) Net Income (Loss) Attributable to Parent USD 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2024.
  • Atara Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$31.8 M, a 57.5% increase year-over-year.
  • Atara Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$233 M, a 8.44% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$276 M, a 20.9% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$228 M, a 32.9% increase from 2021.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$340 M, a 10.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$233 M -$31.8 M +$43 M +57.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$276 M -$60.5 M +$14.1 M +18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$290 M -$69.8 M +$14.3 M +17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$305 M -$71.1 M -$89.6 M -485% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-01
Q1 2023 -$215 M -$74.8 M +$13.3 M +15.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$228 M -$74.6 M +$18.8 M +20.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$247 M -$84.1 M +$573 K +0.68% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$248 M $18.5 M +$102 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 -$350 M -$88.1 M -$9.77 M -12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 -$340 M -$93.3 M -$12 M -14.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-08
Q3 2021 -$328 M -$84.7 M -$10.3 M -13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$318 M -$83.8 M -$6.34 M -8.18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$311 M -$78.3 M -$4.83 M -6.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$307 M -$81.3 M -$2.81 M -3.58% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 -$304 M -$74.3 M -$2.45 M -3.41% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$301 M -$77.5 M -$3.13 M -4.21% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$298 M -$73.5 M -$7.25 M -10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$291 M -$78.5 M +$1.52 M +1.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$292 M -$71.9 M -$13.5 M -23.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$279 M -$74.3 M -$23.4 M -46.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$256 M -$66.3 M -$24.8 M -59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$231 M -$80 M -$44.7 M -127% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$186 M -$58.4 M -$27.3 M -87.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$159 M -$50.9 M -$23.5 M -85.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$135 M -$41.4 M -$15.8 M -61.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$119 M -$35.3 M -$17.1 M -93.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$102 M -$31.1 M -$5.72 M -22.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$96.7 M -$27.4 M -$8.55 M -45.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$88.1 M -$25.7 M -$9.09 M -54.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$79 M -$18.2 M +$3.01 M +14.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$82.1 M -$25.4 M -$13.5 M -114% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$68.6 M -$18.9 M -$3.94 M -26.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$64.6 M -$16.6 M -$7.4 M -80.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$57.2 M -$21.2 M -$10.7 M -102% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$46.5 M -$11.9 M -$5.95 M -101% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$40.6 M -$14.9 M -$10.4 M -231% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$30.1 M -$9.16 M -$2.11 M -29.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$28 M -$10.5 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$5.92 M -$3.38 M -133% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$4.51 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$7.05 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$2.54 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q4 2012 -$4.11 M Aug 22, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.